Introducción: La β2microglobulina está reconocida como marcador tumoral en
hematopatías malignas de estirpe linfoide; sin embargo, no hay antecedentes de su …

Introducción: El uso de biomarcadores en la práctica clínica revolucionó los criterios
diagnósticos, pronósticos y terapéuticos de enfermedades oncológicas. Uno de ellos, la β2 …

La beta 2 microglobulina es una proteína de bajo peso molecular relacionada con el
sistema HL-A, que se encuentra virtualmente en todas las células nucleadas. En pacientes …

Abstract Serum β2-microglobulin (β2M) was measured in 22 patients with B chronic
lymphocytic leukemia (CLL) and in 15 healthy age-matched control subjects. The patients …

Background: In lymphoproliferative disorders serum β2-microglobulin (β2m) can be useful
as a clinical marker. Material and Methods: β2m measurements were carried out with a new …

We read with interest the study by Rossi and coworkers, reporting CD49d expression as risk
factor of treatment free survival (TFS) in Binet A CLL patients. 1 In this paper, a close …

Beta2-microglobulin (B2m) was measured on serum samples in 274 patients with acute and
chronic lymphoproliferative disorders (85 non-Hodgkin lymphomas-NHL, 30 Hodgkin …

Introduction: Multiple myeloma is multifocal neoplasia of plasmatic cells that affects the bone
marrow. It is associated with the production of a urinary or serum protein. It represents …

Abstract purpose: Elevated serum beta-2 microglobulin (β2M) levels are associated with
poor prognosis in several lymphoproliferative disorders including multiple myeloma and …

Objective: The influence of β2-microglobulin (β2-MG) on the prognosis of non-Hodgkin's
lymphoma (NHL) remains controversial. This study performed meta-analyses to evaluate the …